Categories
Latest Industry Intelligence
DDW has published the first of its new Guide Series, Where is the global innovation [...]
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation for iOnctura’s IOA-244, which is in development for solid and hematologic malignancies including uveal melanoma. Uveal melanoma is a disease in which cancer originates in the tissues of the eye, causing symptoms such as blurred vision or a dark spot on the iris. […]
Menu ≡ ╳ 
